Estape J - Search Results

1

C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Muñoz M, Farrus B, Latre ML, Gimenez N, Hage M, Estape J, Ballesta AM. Molina R, et al. Among authors: estape j. Anticancer Res. 1996 Jul-Aug;16(4B):2295-300. Anticancer Res. 1996. PMID: 8694559

2

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

Molina R, Jo J, Zanón G, Filella X, Farrus B, Muñoz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estapé J, Ballesta AM. Molina R, et al. Among authors: estape j. Br J Cancer. 1996 Oct;74(7):1126-31. doi: 10.1038/bjc.1996.501. Br J Cancer. 1996. PMID: 8855986 Free PMC article.

3

Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.

Viñolas N, Molina R, Galán MC, Casas F, Callejas MA, Filella X, Grau JJ, Ballesta AM, Estape J. Viñolas N, et al. Among authors: estape j. Anticancer Res. 1998 Jan-Feb;18(1B):631-4. Anticancer Res. 1998. PMID: 9584045 Clinical Trial.

4

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Mu noz M, Farrus B, Latre ML, Escriche C, Estape J, Ballesta AM. Molina R, et al. Among authors: estape j. Breast Cancer Res Treat. 1998 Sep;51(2):109-19. doi: 10.1023/a:1005734429304. Breast Cancer Res Treat. 1998. PMID: 9879773

5

C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients.

Molina R, Jo J, Filella X, Zanón G, Farrus B, Muñoz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estapé J, Ballesta AM. Molina R, et al. Among authors: estape j. Anticancer Res. 1999 Jul-Aug;19(4A):2551-5. Anticancer Res. 1999. PMID: 10470193

6

Phosphohexose isomerase and carcinoembryonic antigen in the sera of patients with primary lung cancer.

Santabárbara P, Molina R, Estapé J, Ballesta AM. Santabárbara P, et al. Among authors: estape j. Int J Biol Markers. 1988 Apr-Jun;3(2):113-22. doi: 10.1177/172460088800300207. Int J Biol Markers. 1988. PMID: 3243977

7

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.

Molina R, Agusti C, Mañe JM, Filella X, Jo J, Joseph J, Giménez N, Estapé J, Ballesta AM. Molina R, et al. Among authors: estape j. Int J Biol Markers. 1994 Apr-Jun;9(2):96-101. doi: 10.1177/172460089400900206. Int J Biol Markers. 1994. PMID: 7523548 Clinical Trial.

8

TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.

Filella X, Fuster J, Molina R, Grau JJ, García-Valdecasas JC, Grande L, Estapé J, Ballesta AM. Filella X, et al. Among authors: estape j. Acta Oncol. 1994;33(7):747-51. doi: 10.3109/02841869409083943. Acta Oncol. 1994. PMID: 7993641

9

Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.

Galán M, Viñolas N, Colomer D, Soler G, Muñoz M, Longarón R, Ventura PJ, Gascón P, Estapé J. Galán M, et al. Among authors: estape j. Anticancer Res. 2002 Sep-Oct;22(5):2877-84. Anticancer Res. 2002. PMID: 12530011

10

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

Mellado B, Colomer D, Castel T, Muñoz M, Carballo E, Galán M, Mascaró JM, Vives-Corrons JL, Grau JJ, Estapé J. Mellado B, et al. Among authors: estape j. J Clin Oncol. 1996 Jul;14(7):2091-7. doi: 10.1200/JCO.1996.14.7.2091. J Clin Oncol. 1996. PMID: 8683241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters